CD74: a new prognostic factor for patients with malignant pleural mesothelioma
- Otterstrom, Claire
- Soltermann, Alex
- Opitz, I
- Felley-Bosco, E
- Weder, W
- Stahel, R A
- Triponez, Frédéric
- Robert, John
- Serre Beinier, Véronique
Publication date
January 2014
DOI Publisher
Springer Science and Business Media LLCAbstract
The pro-inflammatory cytokine migration inhibitory factor (MIF) and its receptor CD74 have been proposed as possible therapeutic targets in several cancers. We studied the expression of MIF and CD74 together with calretinin in specimens of malignant pleural mesothelioma (MPM), correlating their expression levels with clinico-pathologic parameters, in particular overall survival (OS)
Add to ORKG